Merck KGaA ventures into new territory in the US
Written by
BioPharma Dive
Published
0
comments
0
min
Miguel Fernández Alcalde, head of Merck KGaA’s U.S. arm, aims to “double down” on innovation. The company’s recent SpringWorks deal is just a start.